Detalhe da pesquisa
1.
Immune Modifications in Fetal Membranes Overlying the Cervix Precede Parturition in Humans.
J Immunol
; 198(3): 1345-1356, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031337
2.
High number of CD56(bright) NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections.
Virol J
; 10: 33, 2013 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23351719
3.
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.
Nat Commun
; 14(1): 588, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737440
4.
Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes.
Oncoimmunology
; 11(1): 2057396, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371620
5.
Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy.
Cancers (Basel)
; 13(6)2021 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33810032
6.
Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells.
Blood
; 112(6): 2381-9, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18574028
7.
Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation.
Blood
; 112(12): 4420-4, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18682600
8.
Two-dimensional dynamic evaluation of natural killer cell-mediated lysis of adherent target cells.
Methods Enzymol
; 631: 289-304, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948553
9.
BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.
J Immunother Cancer
; 8(2)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32912923
10.
Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Cancer Res
; 67(12): 5594-9, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17575122
11.
Editorial: New insights into innate immune cell-based immunotherapies in cancer.
Front Immunol
; 15: 1401665, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38655257
12.
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.
Front Immunol
; 10: 661, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30984204
13.
CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes.
Cancer Immunol Res
; 7(2): 208-218, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514793
14.
Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.
Oncoimmunology
; 8(2): e1527498, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30713781
15.
Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.
Haematologica
; 93(3): 381-9, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18268282
16.
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.
Oncoimmunology
; 7(12): e1386826, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30524877
17.
Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets.
Cancer Res
; 65(7): 2914-20, 2005 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15805294
18.
BCR/ABL promotes dendritic cell-mediated natural killer cell activation.
Cancer Res
; 65(14): 6409-17, 2005 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16024645
19.
Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets.
Cell Rep
; 20(12): 2891-2905, 2017 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28930684
20.
Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers.
Front Immunol
; 8: 683, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28659921